Latest

Alzheimer’s Association

·July 30, 2024·4 min read

GLP-1 Drug Slows Alzheimer’s Cognitive Decline

A recent study suggests that a GLP-1 drug, liraglutide, may protect the brains of people with mild Alzheimer’s disease, slowing cognitive decline by 18% over one year. This effect is likely due to the drug’s ability to reduce brain inflammation, improve insulin resistance, and lower the impact of Alzheimer’s biomarkers.

Featured Neurology Neuroscience

·July 28, 2024·8 min read

Blood Tests Revolutionize Alzheimer’s Diagnosis

New research reveals that highly accurate blood tests for Alzheimer's can improve diagnosis accuracy and expedite treatment and research participation. These tests measure biomarkers like phosphorylated tau, which correlate with cognitive decline and brain atrophy.

Featured Neurology Neuroscience

·September 14, 2022·3 min read

Daily Multivitamin Use May Slow Cognitive Aging for Older Adults

Researchers found significant cognitive benefits for older adults who took daily multivitamin-mineral supplements.

Featured Neurology Neuroscience

·July 26, 2021·6 min read

Improving Air Quality Reduces Dementia Risk

Previous studies have linked air pollution to an increased risk of Alzheimer's disease and a number of other disorders. Researchers report reducing air pollution significantly decreases dementia risk and slows cognitive decline in older women.

This is a drawing of a woman with pieces of her blowing away

Featured Neurology

·July 30, 2020·5 min read

Alzheimer’s Risk Factors May Be Measurable in Adolescents and Young Adults

Alzheimer's risk factors could be apparent as early as our teenage years, researchers reports. The risk factors disproportionately affect African Americans and include heart health problems, high cholesterol, diabetes, and insufficient quality of education.

Featured Neurology

·July 27, 2020·5 min read

Flu and Pneumonia Vaccinations Tied to Lower Risk of Alzheimer’s

Being vaccinated against influenza was associated with a 17% reduction in Alzheimer's incidence. Pneumonia vaccinations given between the ages of 65 and 75, reduced Alzheimer's risk by up to 40%.

This shows pet brain imaging scans of a patient with Alzheimer's disease

Featured Neurology Neuroscience

·April 2, 2019·9 min read

Alzheimer’s diagnosis and management improved by brain scans

PET imaging that helps detect dementia-related amyloid plaques significantly influences the clinical management of patients, a new study reports.

Featured Genetics Neurology Open Neuroscience Articles

·September 25, 2018·5 min read

Exercise May Delay Cognitive Decline in People with Rare Alzheimer’s

Researchers report, for those with a genetic mutation that causes Alzheimer's disease, 2.5 hours of physical activity per week may delay cognitive decline and have beneficial effects on tau in the brain. They speculate the same may be true for those with more common forms of the neurodegenerative disease.

Featured Neurology Open Neuroscience Articles

·April 10, 2018·12 min read

Alzheimer’s Disease Redefined

Researchers have published a new research framework that defines Alzheimer's disease by brain changes, not symptoms.

Featured Neurology

·January 17, 2017·5 min read

High Blood Pressure Onset in Late Life May Protect Against Dementia

Researchers report people who reported hypertension onset during their 80's were 42 percent less likely to develop dementia after the age of 90 than those with no history of high blood pressure.